MALIA SERING: Open Payments
NPI 1013198720 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 60 payments from 15 companies in 2025. Trend: 2023 $1,902 · 2024 $3,083 · 2025 $1,354
Food & beverage: $1,157Education: $197
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $227 |
| GENZYME CORPORATION | 7 | $221 |
| Regeneron Healthcare Solutions, Inc. | 5 | $215 |
| Janssen Biotech, Inc. | 4 | $163 |
| Amgen Inc. | 6 | $97 |
| UCB, Inc. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| PFIZER INC. | 3 | $61 |
| Galderma Laboratories, L.P. | 3 | $53 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $42 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, OTEZLA, RINVOQ, Bimzelx, COSENTYX, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
